| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
|
Nat Genet
|
2011
|
10.07
|
|
2
|
Revising the definition of Alzheimer's disease: a new lexicon.
|
Lancet Neurol
|
2010
|
8.74
|
|
3
|
Neuropathologic features of amnestic mild cognitive impairment.
|
Arch Neurol
|
2006
|
6.20
|
|
4
|
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.
|
J Neuropathol Exp Neurol
|
2012
|
3.77
|
|
5
|
Primary age-related tauopathy (PART): a common pathology associated with human aging.
|
Acta Neuropathol
|
2014
|
3.75
|
|
6
|
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.
|
J Neuropathol Exp Neurol
|
2007
|
2.65
|
|
7
|
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons.
|
Brain Pathol
|
2008
|
2.44
|
|
8
|
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.
|
Neurology
|
2012
|
2.19
|
|
9
|
Hippocampal sclerosis in advanced age: clinical and pathological features.
|
Brain
|
2011
|
2.16
|
|
10
|
Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.
|
Arch Neurol
|
2006
|
2.13
|
|
11
|
Novel late-onset Alzheimer disease loci variants associate with brain gene expression.
|
Neurology
|
2012
|
2.08
|
|
12
|
Low sensitivity in clinical diagnoses of dementia with Lewy bodies.
|
J Neurol
|
2009
|
1.73
|
|
13
|
Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.
|
J Neuropathol Exp Neurol
|
2009
|
1.66
|
|
14
|
Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.
|
Acta Neuropathol
|
2011
|
1.62
|
|
15
|
University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.
|
Curr Alzheimer Res
|
2012
|
1.52
|
|
16
|
Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.
|
Exp Neurol
|
2011
|
1.49
|
|
17
|
Human cerebral neuropathology of Type 2 diabetes mellitus.
|
Biochim Biophys Acta
|
2008
|
1.46
|
|
18
|
Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease.
|
Acta Neuropathol
|
2013
|
1.41
|
|
19
|
APOE ε4 increases risk for dementia in pure synucleinopathies.
|
JAMA Neurol
|
2013
|
1.41
|
|
20
|
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.
|
Arch Neurol
|
2012
|
1.32
|
|
21
|
PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.
|
Acta Neuropathol
|
2015
|
1.17
|
|
22
|
Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.
|
Neurosci Lett
|
2008
|
1.15
|
|
23
|
Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing.
|
Brain
|
2013
|
1.13
|
|
24
|
Lewy body pathology in normal elderly subjects.
|
J Neuropathol Exp Neurol
|
2009
|
1.11
|
|
25
|
EEG changes in a patient with steroid-responsive encephalopathy associated with antibodies to thyroperoxidase (SREAT, Hashimoto's encephalopathy).
|
J Clin Neurophysiol
|
2006
|
1.10
|
|
26
|
ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.
|
Acta Neuropathol
|
2014
|
1.07
|
|
27
|
Comparison of recruitment efforts targeted at primary care physicians versus the community at large for participation in Alzheimer disease clinical trials.
|
Alzheimer Dis Assoc Disord
|
2010
|
1.07
|
|
28
|
Association between male gender and cortical Lewy body pathology in large autopsy series.
|
J Neurol
|
2010
|
1.06
|
|
29
|
Screening for C9ORF72 repeat expansion in FTLD.
|
Neurobiol Aging
|
2012
|
1.05
|
|
30
|
Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition.
|
J Alzheimers Dis
|
2011
|
1.03
|
|
31
|
Mild cognitive impairment: statistical models of transition using longitudinal clinical data.
|
Int J Alzheimers Dis
|
2012
|
1.01
|
|
32
|
Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia.
|
J Alzheimers Dis
|
2013
|
0.97
|
|
33
|
APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature.
|
J Neuropathol Exp Neurol
|
2013
|
0.96
|
|
34
|
Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB.
|
J Alzheimers Dis
|
2009
|
0.94
|
|
35
|
"End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?
|
J Alzheimers Dis
|
2011
|
0.90
|
|
36
|
Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohort.
|
Dement Geriatr Cogn Disord
|
2013
|
0.86
|
|
37
|
Rarity of the Alzheimer disease-protective APP A673T variant in the United States.
|
JAMA Neurol
|
2015
|
0.84
|
|
38
|
Substantia nigra depigmentation and exposure to encephalitis lethargica.
|
Ann Neurol
|
2012
|
0.81
|
|
39
|
Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature.
|
J Neuropathol Exp Neurol
|
2015
|
0.80
|
|
40
|
Repeated retrieval during working memory is sensitive to amnestic mild cognitive impairment.
|
J Clin Exp Neuropsychol
|
2013
|
0.78
|
|
41
|
Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment.
|
Curr Psychiatry Rep
|
2012
|
0.77
|
|
42
|
Alzheimer disease: can the exam predict the pathology?
|
Neurology
|
2012
|
0.76
|
|
43
|
Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort.
|
Dement Geriatr Cogn Disord
|
2015
|
0.76
|
|
44
|
Cognitive and brain reserve and the diagnosis and treatment of preclinical Alzheimer disease.
|
Neurology
|
2013
|
0.76
|
|
45
|
Comment: Telomeres in AD--the long and the short of it.
|
Neurology
|
2012
|
0.75
|
|
46
|
The Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease.
|
Alzheimer Dis Assoc Disord
|
2016
|
0.75
|
|
47
|
Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With Sclerosis.
|
Arch Pathol Lab Med
|
2017
|
0.75
|